Your browser doesn't support javascript.
loading
Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome.
Wegner, Rodney E; Abel, Stephen; Monga, Dulabh; Raj, Moses; Finley, Gene; Nosik, Stanislav; McCormick, James; Kirichenko, Alexander V.
Afiliación
  • Wegner RE; Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, USA. Rodney.Wegner@ahn.org.
  • Abel S; Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, USA.
  • Monga D; Division of Medical Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, USA.
  • Raj M; Division of Medical Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, USA.
  • Finley G; Division of Medical Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, USA.
  • Nosik S; Division of Colorectal Surgery, Allegheny Health Network, Pittsburgh, USA.
  • McCormick J; Division of Colorectal Surgery, Allegheny Health Network, Pittsburgh, USA.
  • Kirichenko AV; Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, USA.
Ann Surg Oncol ; 27(3): 825-832, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31720934
BACKGROUND: Adjuvant radiation is generally not recommended for colon cancer but may be considered in certain clinical scenarios [advanced local disease (pT4) and/or positive margins]. Guidelines in this area are lacking; thus we analyzed the National Cancer Database (NCDB) for patterns of care in this regard and any predictors for outcome. METHODS: We queried the NCDB from 2004 to 2016 for patients with resected adenocarcinoma of the colon having pT4 and/or had positive margins on final pathology and who received adjuvant multiagent chemotherapy. Multivariable logistic regression was used to identify predictors of adjuvant radiation. A propensity score was used to perform matched Kaplan-Meier analysis. Propensity-adjusted Cox regression was used to identify predictors of overall survival. RESULTS: We identified 23,325 patients meeting criteria, of whom 1711 (7%) received adjuvant radiation. Median follow-up was 36 months. The majority of patients were pT4 alone (65%). Predictors of adjuvant radiation were lower comorbidity score, younger age, more remote year of treatment, and both pT4 and positive margins. Kaplan-Meier analysis revealed improved overall survival (OS) in patients with both pT4 and positive margins treated with radiation (median OS: 66 versus 47 months, p = 0.02). Receipt of adjuvant radiation was associated with improved OS [hazard ratio (HR): 0.86 (0.80-0.93) p = 0.0002] on Cox regression analysis. Increased age, higher comorbidity score, lower income, government insurance, and combined pT4/positive margins were indicative of worse survival. CONCLUSIONS: Expectedly, adjuvant radiation use was relatively low but was associated with improved OS in patients with both pT4 and positive margins.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias del Colon Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias del Colon Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos